News

Scientists at Jiangnan University in China recently found that there is a specific gut microbe known as Bacteroides vulgatus, ...
A plant compound known as berberine has been called the ‘nature’s Ozempic,' but doctor sheds a reality check if it is similar ...
Weight-loss drugs for dogs are the next big thing in pet healthcare. It’s no bad thing, says Charlotte Cripps, who ...
COMMENT: The monthly cost of a private prescription exceeding £300 from next month is worrying news for the half a million ...
What started as a medical solution to diabetes has exploded into a worldwide weight-loss trend, with demand skyrocketing as ...
Through innovation, cost discipline, legal action, and competitive pricing, Novo Nordisk has reasserted its leadership in the GLP-1 market. With a robust pipeline and global expansion, NVO is poised ...
A Comeback Fueled by Resilience Danish pharmaceutical giant Novo Nordisk (NYSE:NVO) has been a trailblazer in the GLP-1 drug ...
Novo Nordisk lowers Ozempic cost to $499 per month for uninsured U.S. patients, expanding access through NovoCare and 70,000 ...
Hims & Hers Health Inc. HIMS shares are trading lower Tuesday after GoodRx Inc. GDRX announced a collaboration with Novo ...
Novo Nordisk is slashing the price of its blockbuster diabetes drug Ozempic for U.S. patients who self-pay or are uninsured.
The company is the latest facing historic losses as pharmaceutical firms compete to develop a weight-loss pill.
Novo Nordisk announced Monday that U.S. patients can now get a month's supply of Ozempic, the blockbuster diabetes drug, for $499, for those who pay for medications on their own and don't go through ...